Patient-reported outcomes of 905 patients with breast cancer two years after start of curative systemic treatment.

Marschner, N., Trarbach, T., Dörfel, S., Meyer, D., Müller-Hagen, S., Zaiss, M., Boller, E., Kruggel, L., 2016.

Oncol Res Treat 39 (suppl 5)(V385), 116. doi:10.1159/000449050

Studie: TMK; Indikation: Mammakarzinom; Jahr: 2016; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

Ellen-Gottlieb-Straße 19
79106 Freiburg

Tel: 0761 - 15 242 0